Skip to main content
Market intelligence
KYNBSector not reported

KYNTRA BIO, INC. insider activity

In the last 90 days, 1 corporate insider purchased $19,852 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$19,852
Corporate buyers
1
Latest transaction
May 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 14, 2026Thane WettigCEOOpen Market Purchase2,800$7.09$19,852